Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-15

Clinical Trial Update: A Study to Assess Efficacy and Tolerability of Ketoprofen 40 mg Granules vs Placebo [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Ketoprofen 40 mg granules to placebo in acute pain completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoprofen 40 mg granules (ketoprofen)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Acute Pain | Phase 3 | Status: COMPLETED | Results posted: 2024-04-15